Formulary

FDA Update: Report Claims “Power Grab,” Dems Say Hahn Blocked From Testifying

September 20, 2020

Reports say Azar is asserting control over FDA as vaccine trials near completion, while Hahn is blocked from testifying on COVID-19.

The Challenges of Treating Primary Progressive MS

September 13, 2020

A session at MSVirtual2020 covers the difficulty of finding treatments for some forms of MS.

5 Takeaways From the European Society of Cardiology 2020 Congress

September 02, 2020

The 2020 meeting, presented in a virtual format from its original host city of Amsterdam, The Netherlands, had lots of important science and a record number of viewers.

Electronic Prior Authorization is Catching on

August 27, 2020

But there are plenty of holdouts. Half of submissions are still done by phone or fax.

ViiV Healthcare Receives FDA Approval for Drug to Treat Adults with HIV-1

August 08, 2020

Dovato lets adults with HIV reduce the number of antiretroviral therapies they take, while maintaining efficacy and a high barrier to resistance comparable to tenofovir-based regimens.

An Update for Cardiologists Who See Patients With Type 2 Diabetes

August 05, 2020

The American College of Cardiology issues its second set of recommendations for its members on prescribing two groups of drugs first developed for type 2 diabetes.

5 Tips for Employers on Reforming and Optimizing Medication Use

August 04, 2020

Lives can be saved, physician burnout and waste can be reduced, and drug costs can decrease by achieving medication optimization through comprehensive medication management.

Is the Biosimilars Waiting Game Finally Over?

July 30, 2020

Advocates say a number of regulatory changes could help bring more of these products on to the market.